Three multiresistant serotype 6B Streptococcus pneumoniae strains were isolated from the middle ear fluids of children undergoing tympanostomy in Atlanta. Because multiresistant 6B pneumococci have been reported to spread from a single clone, the three isolates were compared with 13 other multiresistant 6B pneumococci by hybridization of endonuclease-restricted DNA fragments with a digoxigenin-labeled cDNA probe complementary to 16 and 23S rRNAs (ribotyping). The ear isolates were heterogeneous, whereas six of the other pneumococcal isolates were alike, indicating a need for additional studies to determine the possibility of clonal spread.
In a recent study, Streptococcus pneumoniae was isolated from the middle ear fluid of 9 of 100 (9%) young children undergoing tympanostomy tube placement in a pediatric practice in Atlanta; eight of these strains were resistant to penicillin or ampicillin. Six of the isolates exhibited multiple resistance to ampicillin, trimethoprim-sulfamethoxazole, cefaclor, and at least one other drug (13) . Three of these multiresistant strains were capsular serotype 6B, suggesting that they might be genetically related. Until recently capsular serotyping has been the primary laboratory typing method for epidemiologic studies, and because of this the strains within a serotype have not been routinely distinguishable (14) .
Using several molecular techniques, investigators have demonstrated diversity within the serotypes of S. pneumoniae (7). Munoz et al. (10) The type strain (IS87), the 3 isolates from patients with otitis, and 13 strains from the Centers for Disease Control and Prevention's collection of multiresistant serotype 6B S. pneumoniae were included for rRNA analysis. Ten of the selected isolates were epidemiologically unrelated (six blood, one throat, one sinus, one ear fluid, and one sputum); three were epidemiologically related isolates from the blood of patients in the same hospital in Texas. The strain number, isolation site, source, and antibiotic patterns are given in Table 1 .
The antimicrobial susceptibility profiles of the organisms were determined by broth microdilution with cation-adjusted Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) supplemented with 5% lysed horse blood as described in publication M7-A2 of the National Committee for Clinical Laboratory Standards (11) .
Growth conditions and chromosomal DNA extraction methods were described previously (5). The DNA was measured spectrophotometrically (2), and DNA was digested with HindIII (Boehringer Mannheim, Indianapolis, Ind.) according to the (16) . Membranes were probed with a nonradioactive digoxigenin-labeled cDNA probe (4) complementary to Escherichia coli 16S and 23S rRNAs (Boehringer Mannheim) as described previously (8, 12) . Hybridized fragments were detected by a color development system with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. Figure 1 shows the HindIII rRNA restricted fragment patterns of S. pneumoniae isolates. The isolates are listed as IS71 through IS87. Lanes 1, 2, and 3 contain the three multiresistant isolates from the Atlanta pediatric practice, and lane 4 contains an isolate taken 2 months later from the patient whose isolate is in lane 3. IS71 (lane 1) has fragments of 1.6, 2.0, 3.1, and 4.0 kb, and IS72 (lane 2) has a doublet at 4.0 kb, with additional bands at 5.6 and 7.8 kb. Isolates IS73 and IS73A (lanes 3 and 4, respectively) are alike and can be differentiated from isolates in the first two lanes by the presence of an additional 9.8-kb fragment. However, IS72 and IS73 were also like IS86 and IS78, respectively. Lanes 5 through 8, 10, and 12 (IS74, IS75, IS76, IS77, IS79, and IS81, respectively) contain epidemiologically unrelated isolates with identical ribotyping patterns. Lane 13 contains an undigested DNA control sample. Lanes 14, 15, and 16 (IS82, IS83, and IS84, respectively) contain isolates from the same hospital in Texas and have identical restriction fragment length polymorphisms. Lane 17 contains an epidemiologically unrelated isolate that is similar to the isolate in lane 2. Lane 18 is IS87, the type strain for 6B S. pneumoniae, which has a unique restriction fragment length polymorphism.
Six different ribotype patterns were identified among the 16 strains and were designated A to F (Table 1) . Ribotype G was assigned to the serotype 6B type strain. The three isolates from ear fluids of children in Atlanta, designated types A, B, and C, respectively, differed from each other. Two of these isolates had ribotypes identical to those of strains from other geographic locations. A second isolate taken from the same patient from whom IS73 was obtained, designated IS73A, was identical to isolate IS73, indicating a possible recurrence or treatment failure. The most common pattern was ribotype D, consisting of six epidemiologically unrelated strains.
In these multiresistant strains, a difference in susceptibility to tetracycline or chloramphenicol did not correlate with a difference in ribotype. This observation had been reported previously (9) . Geographically diverse strains of penicillinsusceptible 6B pneumococci have been reported to demonstrate heterogeneous ribotypes (17) . In our study, six of the multiresistant geographically diverse strains had identical ribotype patterns. The remaining 10 shared five different ribotypes.
We conclude that the ribotypes of the three multiresistant serotype 6B pneumococci from ear fluids in the Atlanta study were different, indicating clonal heterogeneity. However, the presence of a cluster of similar ribotypes in selected multiresistant serotype 6B strains indicates that additional genetic studies are needed to determine if there is a prominent multiresistant clone. Pulsed-field gel electrophoresis of the similar pneumococcal serotype 6B ribotypes may be useful in determining the relatedness of these strains.
